TSS
ACRS icon

Two Sigma Securities’s Aclaris Therapeutics ACRS Stock Holding History

Two Sigma Securities’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.3K Buy
22,471
+10,926
+95% +$36.9K 0.01% 1199
2025
Q4 		$34.8K Buy
11,545
+959
+9% +$2.42K ﹤0.01% 1114
2025
Q3 		$20.1K Buy
+10,586
New +$18.5K ﹤0.01% 1139
2024
Q4 		– Sell
-10,740
Closed -$12.4K – 1575
2024
Q3 		$12.4K Buy
+10,740
New +$13.2K ﹤0.01% 2562
2024
Q2 		– Sell
-16,114
Closed -$20K – 2926
2024
Q1 		$20K Buy
+16,114
New +$19.2K ﹤0.01% 2676

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Securities's ACRS Position: Q1 2026 in Review

Two Sigma Securities increased its Aclaris Therapeutics (ACRS) stake by 95% in Q1 2026, buying an estimated $36.9K and bringing the position to 22,471 shares worth $84.3K. The position accounts for 0.01% of the portfolio, ranked #1199.

Two Sigma Securities first reported a position in ACRS in Q1 2024 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold ACRS as of Q1 2026.

  • Two Sigma Securities held 22,471 shares of Aclaris Therapeutics worth $84.3K as of Q1 2026.
  • Two Sigma Securities bought 10,926 Aclaris Therapeutics shares in Q1 2026, an estimated $36.9K.
  • Aclaris Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1199 holding.
  • Two Sigma Securities first reported a position in Aclaris Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • 136 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.